Novo Nordisk is seeking Chinese approval for its oral weight loss pill
- Novo Nordisk 近 90 天出现 17 次
- 上一次：同一天稍早 · Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
发生了什么
China's drug regulator accepted Novo Nordisk's application for an oral version of Wegovy as the Danish company competes with Eli Lilly in the market
摘要按规则整理自下方来源原文